Diagnostic vétérinaire

Sélectionnez votre pays afin d’obtenir les coordonnées de votre contact

Inscription newsletter

Dermatose Nodulaire Contagieuse / Capripox Virus

ID Screen® Capripox Double Antigen Multi-species

ELISA

Coffret ELISA double antigène pour la détection des anticorps dirigés contre les capripoxvirus, incluant le virus de la dermatose nodulaire contagieuse, le virus de la variole ovine et le virus de la variole caprine, dans le sérum ou le plasma de bovins, ovins, caprins ou autres espèces sensibles

Avantages

Spécifications

Format

Références

Téléchargements

  • Le premier ELISA disponible pour la détection des anticorps dirigés contre la dermatose nodulaire contagieuse (Lumpy Skin Disease)
  • Excellente spécificité pour les zones indemnes (>99.7%). Aucune réaction croisée attendue avec les virus parapox
  • Détection des anticorps dirigés contre la dermatose nodulaire contagieuse chez les animaux vaccinés et infectés. Sensibilité au moins équivalente à l’IPMA, et sensibilité améliorée comparativement à la séroneutralisation (détection des anticorps post-vaccination : dès 20 jours et jusqu’à minimum 7 mois)
  • Facile d’utilisation, fourni avec des réactifs prêts-à-l’emploi, ce kit permet l’analyse d’un grand nombre d’échantillons sans recours à des infrastructures de haute sécurité

Méthode :

ELISA double antigène

Espèces :

Ruminants et autres espèces sensibles

Echantillons :

Sérum et plasma

Antigène sensibilisant :

Antigène purifié CPV

Conjugué :

Antigène purifié CPV-HRP (concentré 10X)

Référence produit

Format du kit

Réactions

Format des plaques

CPVDA-2P 2 plaques 192 Barrettes de 12 x 8 puits
CPVDA-5P 5 plaques 480 Barrettes de 12 x 8 puits
  1. Hussien M.O. et al. (2022). Serological, virological and molecular diagnosis of an outbreak of lumpy skin disease among cattle in Butana area, Eastern Sudan. Veterinary Medicine and Science, 1–7.
  2. Uzar S. et al. (2022). Comparison and efficacy of two different sheep pox vaccines prepared from the Bakırköy strain against lumpy skin disease in cattle. Clin Exp Vaccine Res; 11:1-11.
  3. Ibrahim A.I. et al. (2022). Serodiagnosis of Lumpy Skin Disease Using Sheep Pox Virus Compared to a Commercial ELISA Kit. Journal of Applied Veterinary Sciences, 7(1), pp. 46-52.
  4. Adedeji A.J. et al. (2021) Household and animal factors associated with sheeppox and goatpox sero-prevalence and identification of high-risk areas in selected States of northern Nigeria. Preventive Veterinary Medicine,Volume 196,105473.
  5. Fay P. et al. (2021). A field study evaluating the humoral immune response in Mongolian sheep vaccinated against sheeppox virus. Transboundary and Emerging Diseases , 1-10.
  6. Mansour M. E. et al. (2021). Sero Prevalence and Risk factors for Sheep Pox and Lumpy Skin Disease and Their Comparison to Capri Pox Double Antigen Multispecies ELISA in Khartoum and Kordofan States in Sudan. Archives of Clinical Microbiology, Vol.12 No.S3: 001.
  7. Sanz-Bernardo B. et al. (2021). Quantifying and modeling the acquisition and retention of lumpy skin disease virus by hematophagus insects reveals clinically but not subclinically affected cattleare promoters of viral transmission and key targets for control of disease outbreaks. J Virol 95:e02239-20.
  8. Selim A. et al. (2021). Seroprevalence and risk factors for lumpy skin disease in cattle in Northern Egypt. Tropical Animal Health and Production, 53(3), 1-8.
  9. Wolff J. et al. (2021). Development of a Safe and Highly Efficient Inactivated Vaccine Candidate against Lumpy Skin Disease Virus. Vaccines 9, 4
  10. Kononov A. et al. (2020). Non-vector-borne transmission of lumpy skin disease virus. Scientific reports, 10(1), 1-12.
  11. Krešić N. et al. (2020). Evaluation of serological tests for detection of antibodies against lumpy skin disease virus. Journal of Clinical Microbiology, 58(9)
  12. Milovanović M. et al. (2020). Suitability of individual and bulk milk samples to investigate the humoral immune response to lumpy skin disease vaccination by ELISA. Virology journal, 17(1), 1-7.
  13. Milovanović M. et al.(2020). Suitability of individual and bulk milk samples to investigate the humoral immune response to lumpy skin disease vaccination by ELISA. Virology journal, 17(1), 1-7.
  14. Wolff J. et al. (2020). Establishment of a Challenge Model for Sheeppox Virus Infection. Microorganisms, 8(12), 2001.
  15. Wolff J. et al. (2020). Minimum Infective Dose of a Lumpy Skin Disease Virus Field Strain from North Macedonia. Viruses, 12(7), 768.
  16. Aldeewan, A. B. et al. (2019). Clinical and serological study of Lumpy skin disease in cattle in Basrah Provence. Kufa Journal For Veterinary Medical Sciences, 10(1).
  17. Dawou M. et al. (2019). Prevalence and molecular characterization of Lumpy Skin Disease in cattle during period 2016-2017. Benha Veterinary Medical Journal, 37(1), 172-175.
  18. Milovanović M. et al. (2019). Humoral immune response to repeated lumpy skin disease virus vaccination and performance of serological tests. BMC Veterinary Research 15(1), 1-9
  19. Möller J. et al. (2019). Experimental lumpy skin disease virus infection of cattle: Comparison of a field strain and a vaccine strain. Archives of virology, 164 (12), 2931-2941.
  20. Ochwo S. et al. (2019). Seroprevalence and risk factors for lumpy skin disease virus seropositivity in cattle in Uganda. BMC Veterinary Research 15:236.
  21. Samojlović M. et al. (2019). Detection of antibodies against lumpy skindisease virus by virus neutralization test and elisa methods. Acta Veterinaria-Beograd, 69 (1), 47-60.